The invasive ability of CRC cells was investigated further, results of which were similar to migration assay that IRF6-OE suppressed cell invasion as well as promoted the effect of cisplatin on invasive ability of CRC cells (Figure 5(c,d)). Here, IRF6 is linked to colorectal carcinoma.